431 related articles for article (PubMed ID: 8923095)
1. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
Menting JE; Honig A; Verhey FR; Hartmans M; Rozendaal N; de Vet HC; van Praag HM
Int Clin Psychopharmacol; 1996 Sep; 11(3):165-75. PubMed ID: 8923095
[TBL] [Abstract][Full Text] [Related]
2. [Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].
Montejo AI; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Daniel E; de Dios A; de la Gándara J; Derecho J; Franco M; Gómez MJ; Macías JA; Martín T; Pérez V; Sánchez JM; Sánchez S; Vicens E
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):311-21. PubMed ID: 9054202
[TBL] [Abstract][Full Text] [Related]
3. Depression: making the diagnosis and using SSRIs in the older patient.
Reynolds CF
Geriatrics; 1996 Oct; 51(10):28-34. PubMed ID: 8863755
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of SSRI response.
Salzman C
Harv Rev Psychiatry; 1996; 4(4):215-7. PubMed ID: 9384996
[No Abstract] [Full Text] [Related]
5. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Preskorn S
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
Finley PR
Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
[TBL] [Abstract][Full Text] [Related]
8. Use of serotonin selective reuptake inhibitors in geriatric depression.
Newhouse PA
J Clin Psychiatry; 1996; 57 Suppl 5():12-22. PubMed ID: 8647788
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
Grimsley SR; Jann MW
Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
[TBL] [Abstract][Full Text] [Related]
11. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Montejo-González AL; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Ciudad J; Daniel E; De la Gandara J; Derecho J; Franco M; Gomez MJ; Macias JA; Martin T; Perez V; Sanchez JM; Sanchez S; Vicens E
J Sex Marital Ther; 1997; 23(3):176-94. PubMed ID: 9292833
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Zhang Y; Becker T; Ma Y; Koesters M
BMC Psychiatry; 2014 Aug; 14():245. PubMed ID: 25159460
[TBL] [Abstract][Full Text] [Related]
13. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.
Shen WW; Hsu JH
Int J Psychiatry Med; 1995; 25(3):239-48. PubMed ID: 8567191
[TBL] [Abstract][Full Text] [Related]
14. Response to an open trial of a second SSRI in major depression.
Joffe RT; Levitt AJ; Sokolov ST; Young LT
J Clin Psychiatry; 1996 Mar; 57(3):114-5. PubMed ID: 8617695
[TBL] [Abstract][Full Text] [Related]
15. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Bailly D
Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
Mandrioli R; Mercolini L; Saracino MA; Raggi MA
Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
[TBL] [Abstract][Full Text] [Related]
17. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Carpenter LL; McDougle CJ; Epperson CN; Price LH
Drug Saf; 1996 Aug; 15(2):116-34. PubMed ID: 8884163
[TBL] [Abstract][Full Text] [Related]
18. Milnacipran and selective serotonin reuptake inhibitors in major depression.
Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
[TBL] [Abstract][Full Text] [Related]
19. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
